Skip to main content

Advertisement

Table 1 Association between clinicopathological variables and CNDP2 expression in 150 patients with CC

From: Up-regulation of CNDP2 facilitates the proliferation of colon cancer

Variables n (%) CNDP2 expression Pvalue
   Low High  
Age — yr Mean 57.5 56.2 ± 10.7 58.5 ± 9.5 0.894a
Gender—n (%)     
Male 76 (50.7) 29 (44.6) 47 (55.3) 0.195b
Female 74 (49.3) 36 (55.4) 38 (44.7)  
Tumour size —n (%)   
≤ 5 cm 44 (29.3) 22 (33.3) 22 (26.2) 0.340b
> 5 cm 106 (70.7) 44 (66.7) 62 (73.8)  
Lymph nodes metastasis—n (%)     
No 76 (50.7) 38 (57.6) 38 (45.2) 0.134b
Yes 74 (49.3) 28 (42.4) 46 (54.8)  
Tumour grade—n (%)     
1 20 (21.5) 8 (32.4) 12 (7.1) 0.434b
2 106 (53.9) 50 (46.0) 56 (64.3)  
3 24 (24.6) 8 (21.6) 16 (28.6)  
Tumor stage—n (%)     
I 24 (16.0) 12 (18.2) 12 (14.2) 0.927b
II 46 (30.7) 20 (30.3) 26 (31.0)  
III 62 (41.3) 26 (39.4) 36 (42.9)  
IV 18 (12.0) 8 (12.1) 10 (11.9)  
CEA—n (%)     
Negative 96 (64.0) 44 (63.8) 52 (64.2) 0.956b
Positive 54 (36.0) 25 (36.2) 29 (35.8)  
Tumor location—n (%)
RCC 84 (56.0) 28 (42.4) 56 (66.7) 0.003b*
LCC 66 (44.0) 38 (57.6) 28 (33.3)  
RCC—n (%)
Male 42 (50.0) 9 (33.3) 33 (57.9) 0.035b*
Female 42 (50.0) 18 (66.7) 24 (42.1)  
LCC—n (%)
Male 34 (51.5) 20 (52.6) 14 (50.0) 0.833b
Female 32 (48.5) 18 (47.4) 14 (50.0)  
  1. aMann-whitney u test.
  2. bPearson Chi-Square test.
  3. *Statistically significant.